Global pharmaceutical giant, AstraZeneca, has published its views on the recent report published by England’s Chief Medical Officer on the rise in drug-resistant bacteria being a worldwide ...

A variety of medical device innovations and diagnostics have been named by Time as some of the best inventions of 2024.

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

Prof. Dr. Luong Ngoc Khue - Vice Chairman - National Medical Council, cum Director of the MSA Department) and AstraZeneca Vietnam (represented by Mr. Nitin Kapoor, Chairman and General Director, ...

New indication supported by the MANDARA trial, which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids LONDON, UK I October 28, 2024 I ...

A Covid vaccine compensation scheme could be set up after thousands claimed they have been left disabled as a result of the AstraZeneca jab, The Telegraph has learnt. The Health Secretary is ...

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s new drug, Wainzua, has been recommended for approval in the EU for treating hereditary transthyretin-mediated amyloidosis, providing a ...

AstraZeneca reaffirmed its commitment to combating infectious ... In addition, vaccine effectiveness data on FluMist, the only self-administered flu vaccine approved in the US, will be presented. Real ...

FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for self-administration by patients aged 18-49. FluMist is the first influenza ...